Psychotic complications of long‐term levodopa treatment of Parkinson's disease
Identifieur interne : 003151 ( Main/Corpus ); précédent : 003150; suivant : 003152Psychotic complications of long‐term levodopa treatment of Parkinson's disease
Auteurs : A. Friedman ; J. SienkiewiczSource :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 1991-08.
English descriptors
Abstract
ABSTRACT The prevalence of psychotic complications of levodopa treatment was assessed in 198 Parkinson patients. The symptoms were seen in 44 (22.2%). Those who developed complications were significantly older at disease onset (63.3 ± 9.2 vs 57.6 ± 11.6). The observed psychiatric symptoms were classified into two categories: simple, including incidents of confusion alone or hallucinations with preserved insight, and complex, including delusions or chronic confusion without preserved insight. Patients with complex symptoms were significantly younger at the onset of the disease, and the duration of the disease prior to these psychiatric symptoms was longer than in the group of patients with simple symptomatology. Patients with complex symptoms were more susceptible to another central side‐effect of the treatment: dyskinesias, than those with simple.
Url:
DOI: 10.1111/j.1600-0404.1991.tb04918.x
Links to Exploration step
ISTEX:4FE2516B2E833A36FE237FE08189F7DF60868966Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title><author><name sortKey="Friedman, A" sort="Friedman, A" uniqKey="Friedman A" first="A." last="Friedman">A. Friedman</name><affiliation><mods:affiliation>Department of Neurology, Warsaw Medical Academy, Poland</mods:affiliation></affiliation></author><author><name sortKey="Sienkiewicz, J" sort="Sienkiewicz, J" uniqKey="Sienkiewicz J" first="J." last="Sienkiewicz">J. Sienkiewicz</name><affiliation><mods:affiliation>Department of Neurology, Warsaw Medical Academy, Poland</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4FE2516B2E833A36FE237FE08189F7DF60868966</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1111/j.1600-0404.1991.tb04918.x</idno><idno type="url">https://api.istex.fr/document/4FE2516B2E833A36FE237FE08189F7DF60868966/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">003151</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title><author><name sortKey="Friedman, A" sort="Friedman, A" uniqKey="Friedman A" first="A." last="Friedman">A. Friedman</name><affiliation><mods:affiliation>Department of Neurology, Warsaw Medical Academy, Poland</mods:affiliation></affiliation></author><author><name sortKey="Sienkiewicz, J" sort="Sienkiewicz, J" uniqKey="Sienkiewicz J" first="J." last="Sienkiewicz">J. Sienkiewicz</name><affiliation><mods:affiliation>Department of Neurology, Warsaw Medical Academy, Poland</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1991-08">1991-08</date><biblScope unit="volume">84</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="111">111</biblScope><biblScope unit="page" to="113">113</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">4FE2516B2E833A36FE237FE08189F7DF60868966</idno><idno type="DOI">10.1111/j.1600-0404.1991.tb04918.x</idno><idno type="ArticleID">ANE111</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>levodopa</term><term>psychotic complications</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">ABSTRACT The prevalence of psychotic complications of levodopa treatment was assessed in 198 Parkinson patients. The symptoms were seen in 44 (22.2%). Those who developed complications were significantly older at disease onset (63.3 ± 9.2 vs 57.6 ± 11.6). The observed psychiatric symptoms were classified into two categories: simple, including incidents of confusion alone or hallucinations with preserved insight, and complex, including delusions or chronic confusion without preserved insight. Patients with complex symptoms were significantly younger at the onset of the disease, and the duration of the disease prior to these psychiatric symptoms was longer than in the group of patients with simple symptomatology. Patients with complex symptoms were more susceptible to another central side‐effect of the treatment: dyskinesias, than those with simple.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>A. Friedman</name><affiliations><json:string>Department of Neurology, Warsaw Medical Academy, Poland</json:string></affiliations></json:item><json:item><name>J. Sienkiewicz</name><affiliations><json:string>Department of Neurology, Warsaw Medical Academy, Poland</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>levodopa</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>psychotic complications</value></json:item></subject><articleId><json:string>ANE111</json:string></articleId><language><json:string>eng</json:string></language><abstract>ABSTRACT The prevalence of psychotic complications of levodopa treatment was assessed in 198 Parkinson patients. The symptoms were seen in 44 (22.2%). Those who developed complications were significantly older at disease onset (63.3 ± 9.2 vs 57.6 ± 11.6). The observed psychiatric symptoms were classified into two categories: simple, including incidents of confusion alone or hallucinations with preserved insight, and complex, including delusions or chronic confusion without preserved insight. Patients with complex symptoms were significantly younger at the onset of the disease, and the duration of the disease prior to these psychiatric symptoms was longer than in the group of patients with simple symptomatology. Patients with complex symptoms were more susceptible to another central side‐effect of the treatment: dyskinesias, than those with simple.</abstract><qualityIndicators><score>3.952</score><pdfVersion>1.5</pdfVersion><pdfPageSize>576 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>3</keywordCount><abstractCharCount>859</abstractCharCount><pdfWordCount>1476</pdfWordCount><pdfCharCount>9733</pdfCharCount><pdfPageCount>3</pdfPageCount><abstractWordCount>123</abstractWordCount></qualityIndicators><title>Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title><genre><json:string>article</json:string></genre><host><volume>84</volume><publisherId><json:string>ANE</json:string></publisherId><pages><total>3</total><last>113</last><first>111</first></pages><issn><json:string>0001-6314</json:string></issn><issue>2</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1600-0404</json:string></eissn><title>Acta Neurologica Scandinavica</title><doi><json:string>10.1111/(ISSN)1600-0404</json:string></doi></host><publicationDate>1991</publicationDate><copyrightDate>1991</copyrightDate><doi><json:string>10.1111/j.1600-0404.1991.tb04918.x</json:string></doi><id>4FE2516B2E833A36FE237FE08189F7DF60868966</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/4FE2516B2E833A36FE237FE08189F7DF60868966/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/4FE2516B2E833A36FE237FE08189F7DF60868966/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/4FE2516B2E833A36FE237FE08189F7DF60868966/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><p>WILEY</p></availability><date>1991</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title><author><persName><forename type="first">A.</forename><surname>Friedman</surname></persName><note type="correspondence"><p>Correspondence: Andrzej Friedman, Neurological Department, Warsaw Medical Academy, ul. Bancha 1a, 02‐097 Warszawa, Poland</p></note><affiliation>Department of Neurology, Warsaw Medical Academy, Poland</affiliation></author><author><persName><forename type="first">J.</forename><surname>Sienkiewicz</surname></persName><affiliation>Department of Neurology, Warsaw Medical Academy, Poland</affiliation></author></analytic><monogr><title level="j">Acta Neurologica Scandinavica</title><idno type="pISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><idno type="DOI">10.1111/(ISSN)1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1991-08"></date><biblScope unit="volume">84</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="111">111</biblScope><biblScope unit="page" to="113">113</biblScope></imprint></monogr><idno type="istex">4FE2516B2E833A36FE237FE08189F7DF60868966</idno><idno type="DOI">10.1111/j.1600-0404.1991.tb04918.x</idno><idno type="ArticleID">ANE111</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1991</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>ABSTRACT The prevalence of psychotic complications of levodopa treatment was assessed in 198 Parkinson patients. The symptoms were seen in 44 (22.2%). Those who developed complications were significantly older at disease onset (63.3 ± 9.2 vs 57.6 ± 11.6). The observed psychiatric symptoms were classified into two categories: simple, including incidents of confusion alone or hallucinations with preserved insight, and complex, including delusions or chronic confusion without preserved insight. Patients with complex symptoms were significantly younger at the onset of the disease, and the duration of the disease prior to these psychiatric symptoms was longer than in the group of patients with simple symptomatology. Patients with complex symptoms were more susceptible to another central side‐effect of the treatment: dyskinesias, than those with simple.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's disease</term></item><item><term>levodopa</term></item><item><term>psychotic complications</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1991-08">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/4FE2516B2E833A36FE237FE08189F7DF60868966/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1600-0404</doi><issn type="print">0001-6314</issn><issn type="electronic">1600-0404</issn><idGroup><id type="product" value="ANE"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="ACTA NEUROLOGICA SCANDINAVICA">Acta Neurologica Scandinavica</title></titleGroup></publicationMeta><publicationMeta level="part" position="08002"><doi origin="wiley">10.1111/ane.1991.84.issue-2</doi><numberingGroup><numbering type="journalVolume" number="84">84</numbering><numbering type="journalIssue" number="2">2</numbering></numberingGroup><coverDate startDate="1991-08">August 1991</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="0011100" status="forIssue"><doi origin="wiley">10.1111/j.1600-0404.1991.tb04918.x</doi><idGroup><id type="unit" value="ANE111"></id></idGroup><countGroup><count type="pageTotal" number="3"></count></countGroup><titleGroup><title type="tocHeading1">Original Article</title></titleGroup><copyright>1991 Blackwell Munksgaard</copyright><eventGroup><event type="firstOnline" date="2009-01-29"></event><event type="publishedOnlineFinalForm" date="2009-01-29"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.6 mode:FullText source:HeaderRef result:HeaderRef" date="2010-04-20"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="111">111</numbering><numbering type="pageLast" number="113">113</numbering></numberingGroup><correspondenceTo>Andrzej Friedman, Neurological Department, Warsaw Medical Academy, ul. Bancha 1a, 02‐097 Warszawa, Poland</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:ANE.ANE111.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Accepted for publication January 21, 1991</unparsedEditorialHistory><countGroup><count type="referenceTotal" number="15"></count><count type="linksCrossRef" number="3"></count></countGroup><titleGroup><title type="main">Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>A.</givenNames><familyName>Friedman</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>J.</givenNames><familyName>Sienkiewicz</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="PL"><unparsedAffiliation>Department of Neurology, Warsaw Medical Academy, Poland</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">Parkinson's disease</keyword><keyword xml:id="k2">levodopa</keyword><keyword xml:id="k3">psychotic complications</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p><b>ABSTRACT</b> The prevalence of psychotic complications of levodopa treatment was assessed in 198 Parkinson patients. The symptoms were seen in 44 (22.2%). Those who developed complications were significantly older at disease onset (63.3 ± 9.2 vs 57.6 ± 11.6). The observed psychiatric symptoms were classified into two categories: simple, including incidents of confusion alone or hallucinations with preserved insight, and complex, including delusions or chronic confusion without preserved insight. Patients with complex symptoms were significantly younger at the onset of the disease, and the duration of the disease prior to these psychiatric symptoms was longer than in the group of patients with simple symptomatology. Patients with complex symptoms were more susceptible to another central side‐effect of the treatment: dyskinesias, than those with simple.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title></titleInfo><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Friedman</namePart><affiliation>Department of Neurology, Warsaw Medical Academy, Poland</affiliation><description>Correspondence: Andrzej Friedman, Neurological Department, Warsaw Medical Academy, ul. Bancha 1a, 02‐097 Warszawa, Poland</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Sienkiewicz</namePart><affiliation>Department of Neurology, Warsaw Medical Academy, Poland</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">1991-08</dateIssued><edition>Accepted for publication January 21, 1991</edition><copyrightDate encoding="w3cdtf">1991</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">15</extent></physicalDescription><abstract lang="en">ABSTRACT The prevalence of psychotic complications of levodopa treatment was assessed in 198 Parkinson patients. The symptoms were seen in 44 (22.2%). Those who developed complications were significantly older at disease onset (63.3 ± 9.2 vs 57.6 ± 11.6). The observed psychiatric symptoms were classified into two categories: simple, including incidents of confusion alone or hallucinations with preserved insight, and complex, including delusions or chronic confusion without preserved insight. Patients with complex symptoms were significantly younger at the onset of the disease, and the duration of the disease prior to these psychiatric symptoms was longer than in the group of patients with simple symptomatology. Patients with complex symptoms were more susceptible to another central side‐effect of the treatment: dyskinesias, than those with simple.</abstract><subject lang="en"><genre>Keywords</genre><topic>Parkinson's disease</topic><topic>levodopa</topic><topic>psychotic complications</topic></subject><relatedItem type="host"><titleInfo><title>Acta Neurologica Scandinavica</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0001-6314</identifier><identifier type="eISSN">1600-0404</identifier><identifier type="DOI">10.1111/(ISSN)1600-0404</identifier><identifier type="PublisherID">ANE</identifier><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>111</start><end>113</end><total>3</total></extent></part></relatedItem><identifier type="istex">4FE2516B2E833A36FE237FE08189F7DF60868966</identifier><identifier type="DOI">10.1111/j.1600-0404.1991.tb04918.x</identifier><identifier type="ArticleID">ANE111</identifier><accessCondition type="use and reproduction" contentType="copyright">1991 Blackwell Munksgaard</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003151 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 003151 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:4FE2516B2E833A36FE237FE08189F7DF60868966
|texte= Psychotic complications of long‐term levodopa treatment of Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |